Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/s41467-017-02653-3.

Title:
USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A | Nature Communications
Description:
BRCA1-BARD1-catalyzed ubiquitination of histone H2A is an important regulator of the DNA damage response, priming chromatin for repair by homologous recombination. However, no specific deubiquitinating enzymes (DUBs) are known to antagonize this function. Here we identify ubiquitin specific protease-48 (USP48) as a H2A DUB, specific for the C-terminal BRCA1 ubiquitination site. Detailed biochemical analysis shows that an auxiliary ubiquitin, an additional ubiquitin that itself does not get cleaved, modulates USP48 activity, which has possible implications for its regulation in vivo. In cells we reveal that USP48 antagonizes BRCA1 E3 ligase function and in BRCA1-proficient cells loss of USP48 results in positioning 53BP1 further from the break site and in extended resection lengths. USP48 repression confers a survival benefit to cells treated with camptothecin and its activity acts to restrain gene conversion and mutagenic single-strand annealing. We propose that USP48 promotes genome stability by antagonizing BRCA1 E3 ligase function. BRCA1 ligase activity is tightly regulated to maintain genome stability and confer DNA double strand repair. Here the authors identify USP48 as a H2A deubiquitinating enzyme that acts as a BRCA1 E3 ligase antagonist and characterize its role during DNA repair.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {๐Ÿ“š}

  • Science
  • Education
  • Telecommunications

Content Management System {๐Ÿ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of nature.com audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {๐Ÿ’ธ}


Display Ads {๐ŸŽฏ}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {๐Ÿ’ฐ}


Display Ads {๐ŸŽฏ}

$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,616.

Keywords {๐Ÿ”}

usp, cells, pubmed, fig, article, resection, brca, ubiquitin, google, scholar, dna, cas, supplementary, buffer, nacl, repair, cell, rad, substrate, data, protein, activity, habrcaub, lysis, site, sample, central, cleavage, column, ubiquitinated, ssa, foci, nature, ubiquitination, haub, ligase, purified, expression, healthcare, analysis, loss, expressed, beads, biol, lengths, concentration, function, protease, auxiliary, tris,

Topics {โœ’๏ธ}

nature portfolio ez-link sulfo-nhs-lc-biotin biomedical research privacy policy swi/snf-related helicase smarcad12 blm-dna2 helicase/endonuclease complexes ice-cold phosphate-buffered saline advertising 400โ€‰ฮผm isopropyl ฮฒ-d-1-thiogalactopyranoside reprints breast cancer-derived mutation resulting single-stranded dna middle nature 477 nature 431 nature 499 nature 449 nature 532 nature histone-h2a-specific ubiquitin ligase hela-flpin egfp-usp48iso1 cells double-strand break repair dna double-strand breaks double-strand dna breaks disruptive zinc-ligating variant single-strand annealing pathway cleaving brca-initiated ubiquitination preventing large-scale rearrangements brca1-bard1-usp48 circuit promotes long-range resection10 usp48-positive laser lines uniprot identifier q86uv5-2/usp48iso2 ring heterodimer brca1-bard1 uncleavable h2a-ub fusion quantified usp48-catalyzed cleavage original author homology-directed dna repair mutagenic single-strand annealing disrupt damage-signaling dependent social media possibly allowing cross-talk brca1โ€“bard1 nucleosome recognition k27-linked di-ubiquitin smarcad1-mediated nucleosome sliding }\frac{{k_{obs\left serum-free insectxpress medium hela-flag-usp48-c98siso2 sided mannโ€“whitney test brdu-sensitized hela cells anti-h2a western blotting

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A
         description:BRCA1-BARD1-catalyzed ubiquitination of histone H2A is an important regulator of the DNA damage response, priming chromatin for repair by homologous recombination. However, no specific deubiquitinating enzymes (DUBs) are known to antagonize this function. Here we identify ubiquitin specific protease-48 (USP48) as a H2A DUB, specific for the C-terminal BRCA1 ubiquitination site. Detailed biochemical analysis shows that an auxiliary ubiquitin, an additional ubiquitin that itself does not get cleaved, modulates USP48 activity, which has possible implications for its regulation in vivo. In cells we reveal that USP48 antagonizes BRCA1 E3 ligase function and in BRCA1-proficient cells loss of USP48 results in positioning 53BP1 further from the break site and in extended resection lengths. USP48 repression confers a survival benefit to cells treated with camptothecin and its activity acts to restrain gene conversion and mutagenic single-strand annealing. We propose that USP48 promotes genome stability by antagonizing BRCA1 E3 ligase function. BRCA1 ligase activity is tightly regulated to maintain genome stability and confer DNA double strand repair. Here the authors identify USP48 as a H2A deubiquitinating enzyme that acts as a BRCA1 E3 ligase antagonist and characterize its role during DNA repair.
         datePublished:2018-01-15T00:00:00Z
         dateModified:2018-01-15T00:00:00Z
         pageStart:1
         pageEnd:16
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41467-017-02653-3
         keywords:
            Breast cancer
            Homologous recombination
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig6_HTML.jpg
         isPartOf:
            name:Nature Communications
            issn:
               2041-1723
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Michael Uckelmann
               affiliation:
                     name:Netherlands Cancer Institute
                     address:
                        name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ruth M. Densham
               affiliation:
                     name:University of Birmingham
                     address:
                        name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Roy Baas
               affiliation:
                     name:Netherlands Cancer Institute
                     address:
                        name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Herrie H. K. Winterwerp
               affiliation:
                     name:Netherlands Cancer Institute
                     address:
                        name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alexander Fish
               affiliation:
                     name:Netherlands Cancer Institute
                     address:
                        name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Titia K. Sixma
               affiliation:
                     name:Netherlands Cancer Institute
                     address:
                        name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Joanna R. Morris
               affiliation:
                     name:University of Birmingham
                     address:
                        name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A
      description:BRCA1-BARD1-catalyzed ubiquitination of histone H2A is an important regulator of the DNA damage response, priming chromatin for repair by homologous recombination. However, no specific deubiquitinating enzymes (DUBs) are known to antagonize this function. Here we identify ubiquitin specific protease-48 (USP48) as a H2A DUB, specific for the C-terminal BRCA1 ubiquitination site. Detailed biochemical analysis shows that an auxiliary ubiquitin, an additional ubiquitin that itself does not get cleaved, modulates USP48 activity, which has possible implications for its regulation in vivo. In cells we reveal that USP48 antagonizes BRCA1 E3 ligase function and in BRCA1-proficient cells loss of USP48 results in positioning 53BP1 further from the break site and in extended resection lengths. USP48 repression confers a survival benefit to cells treated with camptothecin and its activity acts to restrain gene conversion and mutagenic single-strand annealing. We propose that USP48 promotes genome stability by antagonizing BRCA1 E3 ligase function. BRCA1 ligase activity is tightly regulated to maintain genome stability and confer DNA double strand repair. Here the authors identify USP48 as a H2A deubiquitinating enzyme that acts as a BRCA1 E3 ligase antagonist and characterize its role during DNA repair.
      datePublished:2018-01-15T00:00:00Z
      dateModified:2018-01-15T00:00:00Z
      pageStart:1
      pageEnd:16
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41467-017-02653-3
      keywords:
         Breast cancer
         Homologous recombination
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-017-02653-3/MediaObjects/41467_2017_2653_Fig6_HTML.jpg
      isPartOf:
         name:Nature Communications
         issn:
            2041-1723
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Michael Uckelmann
            affiliation:
                  name:Netherlands Cancer Institute
                  address:
                     name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ruth M. Densham
            affiliation:
                  name:University of Birmingham
                  address:
                     name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Roy Baas
            affiliation:
                  name:Netherlands Cancer Institute
                  address:
                     name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Herrie H. K. Winterwerp
            affiliation:
                  name:Netherlands Cancer Institute
                  address:
                     name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alexander Fish
            affiliation:
                  name:Netherlands Cancer Institute
                  address:
                     name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Titia K. Sixma
            affiliation:
                  name:Netherlands Cancer Institute
                  address:
                     name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Joanna R. Morris
            affiliation:
                  name:University of Birmingham
                  address:
                     name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Nature Communications
      issn:
         2041-1723
      volumeNumber:9
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Netherlands Cancer Institute
      address:
         name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:University of Birmingham
      address:
         name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK
         type:PostalAddress
      name:Netherlands Cancer Institute
      address:
         name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Netherlands Cancer Institute
      address:
         name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Netherlands Cancer Institute
      address:
         name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Netherlands Cancer Institute
      address:
         name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:University of Birmingham
      address:
         name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Michael Uckelmann
      affiliation:
            name:Netherlands Cancer Institute
            address:
               name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Ruth M. Densham
      affiliation:
            name:University of Birmingham
            address:
               name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK
               type:PostalAddress
            type:Organization
      name:Roy Baas
      affiliation:
            name:Netherlands Cancer Institute
            address:
               name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Herrie H. K. Winterwerp
      affiliation:
            name:Netherlands Cancer Institute
            address:
               name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Alexander Fish
      affiliation:
            name:Netherlands Cancer Institute
            address:
               name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Titia K. Sixma
      affiliation:
            name:Netherlands Cancer Institute
            address:
               name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Joanna R. Morris
      affiliation:
            name:University of Birmingham
            address:
               name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK
      name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Division of Biochemistry and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham, UK

External Links {๐Ÿ”—}(263)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {โœ‰๏ธ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {๐Ÿ“ฆ}

  • Crossref

5.06s.